Want to join the conversation?
$BIIB said that the Committee of Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommended the approval of its Tysabri product. The opinion of the CHMP is now referred to the European Commission for final decision on approval. Tysabri is a therapy for the treatment of patients with relapsing forms of multiple sclerosis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?